Pro-Gastrin-Releasing Peptide as a Biomarker in Lung Neuroendocrine Neoplasm

SIMPLE SUMMARY: The aim of this study was to evaluate the diagnostic effectiveness of pro-gastrin-releasing peptide (ProGRP) and chromogranin A (CgA) in the diagnosis of neuroendocrine neoplasms of the lung (LNENs), (290 cases) and compared these results with controls (54 cases). The median ProGRP l...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosiek, Violetta, Kogut, Angelika, Kos-Kudła, Beata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340053/
https://www.ncbi.nlm.nih.gov/pubmed/37444393
http://dx.doi.org/10.3390/cancers15133282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340053/
https://www.ncbi.nlm.nih.gov/pubmed/37444393
http://dx.doi.org/10.3390/cancers15133282

Ejemplares similares